获得的X因子缺乏症的全球流行病学
Kristy Iglay1, Molly L Aldridge1, Mirella Calcinai2
1Real-world Evidence and Patient Outcomes, CERobs Consulting, LLC, Wrightsville Beach, NC, USA.
Hematology (Amsterdam, Netherlands)
|March 28, 2025
概括
获得的X因子缺乏是罕见的,特别是当与轻链粉样性粉症相关时. 需要更多的数据来标准化定义,并更好地了解这种罕见的出血障碍.
科学领域:
- 血液学 血液学 血液学
- 罕见疾病是一种罕见的疾病.
- 流行病学 流行病学
背景情况:
- 获得的X因子缺乏症是一种罕见的出血障碍.
- 它最常与轻链 (AL) 氨基粉症有关.
- 了解其全球发病率和流行率至关重要.
研究的目的:
- 总结有关获得的X因子缺乏的全球发病率和患病率的现有数据.
- 要区分与AL氨基粉症和其他原因相关的获得X因子缺乏症.
- 识别知识缺口和未来研究领域.
主要方法:
- 一个全面的文学评论的英语出版物从PubMed和Embase.
- 对报告获得的X因子缺乏与AL氨基粉症相关的出版物的分析.
- 分析报道从其他原因获得的X因子缺乏的出版物.
主要成果:
- 没有确定AL-粉症相关的获得X因子缺乏症的确切的全球发病率或流行率估计.
- 大约6-14%的AL氨基粉症患者的X因子活性降低,表明罕见.
- 确定了35例与AL氨基粉症无关的获得X因子缺乏病例,其中大多数患有出血事件.
结论:
- 根据有限的数据,获得的X因子缺乏似乎是一种罕见的疾病.
- 为了保持一致的研究和临床实践,需要为获得的X因子缺乏症提供标准化的定义.
- 需要进一步的基于人口的研究,以更好地了解其流行病学.
相关概念视频
Factors Affecting Illness
When a person's physical, emotional, intellectual, social development or spiritual functioning is compromised, this deviation from a healthy normal state is called illness. Illness creates stress that in turn harms individuals. Irritation, anger, denial, hopelessness, and fear are behavioral and emotional changes an individual experiences in the phases of illness. A variety of factors influence a person's health and well-being.
For instance, risk factors are connected to illness, disability,...
For instance, risk factors are connected to illness, disability,...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Extrinsic and Intrinsic Pathways of Hemostasis
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
Disorders of Hemostasis
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...


